1 Min Read
March 28(Reuters) - Starlake Bioscience :
* Says it canceled plan to buy up to 35 percent stake in a Guangzhou-based pharma company
Source text in Chinese: goo.gl/Nkyi5H
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.